2012
DOI: 10.1590/s0365-05962012000500002
|View full text |Cite
|
Sign up to set email alerts
|

Action of topical mometasone on the pigmented halos of micrografting in patients with vitiligo

Abstract: BACKGROUND: Vitiligo is a prevalent skin pigmentation disorder worldwide. The treatments available still offer limited results to some patients. For patients with clinically stable vitiligo, melanocyte transplantation is an appropriate treatment option, and the technique of autologous punch grafting shows good repigmentation. OBJECTIVE: To evaluate the effect of topical mometasone on the halos of repigmentation after autologous punch grafting in patients with clinically stable vitiligo. METHODS: Between 2009 a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 16 publications
0
7
0
Order By: Relevance
“…There are certain adverse effects found with larger grafts such as cobblestoning which has been corrected with electro fulguration. Studies also proved that punch graft combined with NBUV or topical corticosteroid gives much better results [53,54].…”
Section: Punch Graftingmentioning
confidence: 95%
“…There are certain adverse effects found with larger grafts such as cobblestoning which has been corrected with electro fulguration. Studies also proved that punch graft combined with NBUV or topical corticosteroid gives much better results [53,54].…”
Section: Punch Graftingmentioning
confidence: 95%
“…40,41 The micrografting approach can be also used for treatment of vitiligo by melanocyte transplant or autologous punch grafting, resulting in rapid and satisfactory pigmentation. 42,43 In recent years, a new clinical approach has been developed related to the micrografting concept, called "Rigenera micrografting technology" (Human Brain Wave LLC, Turin, Italy). The objective of this technology is to mechanically disaggregate autologous tissue, with a calibrated size of 80 mm, collecting autologous micrografts enriched in progenitor cells, growth factors, and particles of extracellular matrix derived from the patient's own tissue.…”
Section: Micrografting: Theory and Applicationsmentioning
confidence: 99%
“…50 Evidences also suggest that the association of PG with phototherapy (narrowband UVB) and topical corticosteroids may enhance therapeutic results for this technique. 51,52 …”
Section: Vitiligo Treatmentmentioning
confidence: 99%